Grupo Ferrer Internacional SA

Spanish pharmaceutical group with its head office in Barcelona, founded in 1959 and family owned, working in more than a hundred countries and reorganised in recent years around treatments for rare and serious conditions. Develops, makes and sells prescription medicines in neurology and rare disease including pulmonary arterial hypertension and amyotrophic lateral sclerosis, together with consumer health products and specialty ingredients, and runs its own manufacturing plants and research, analytical and quality control laboratories in Spain.